BOSTON SCIENTIFIC CORPORATION Restricted Cash and Cash Equivalents
BOSTON SCIENTIFIC CORPORATION (BSX) had Restricted Cash and Cash Equivalents of $812.00 million as of 2018-09-30, per its 10-Q filed 2018-10-29.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2018-10-29
- 2018-09-30: Restricted Cash and Cash Equivalents $812.00M.
- 2018-06-30: Restricted Cash and Cash Equivalents $787.00M.
- 2017-12-31: Restricted Cash and Cash Equivalents $829.00M.
- 2017-09-30: Restricted Cash and Cash Equivalents $449.00M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2018-09-30 | $812.00M 10-Q · filed 2018-10-29 |
| 2018-06-30 | $787.00M 10-Q · filed 2018-07-31 |
| 2017-12-31 | $829.00M 10-Q · filed 2018-10-29 |
| 2017-09-30 | $449.00M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $251.00M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $127.00M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $243.00M 10-Q · filed 2017-11-02 |
| 2015-12-31 | $54.00M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |